Tissue Regenix Group plc (AIM:TRX)

Tissue Regenix Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	May 9, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	23	37	40	38	38	12
Market Cap Growth	30.33%	-7.68%	5.65%	-0.93%	227.82%	-84.61%
Enterprise Value	28	40	41	36	27	7
Last Close Price	0.33	0.52	0.56	0.54	0.54	1.00
PS Ratio	0.92	1.58	1.95	2.57	3.14	0.89
PB Ratio	1.00	1.59	1.57	1.52	1.35	0.47
P/TBV Ratio	1.97	2.75	2.72	2.53	2.15	1.60
P/FCF Ratio	-	74.38	-	-	-	-
P/OCF Ratio	81.73	44.85	-	-	-	-
EV/Sales Ratio	1.12	1.74	2.01	2.45	2.21	0.52
EV/EBITDA Ratio	25.78	113.67	-	-	-	-
EV/FCF Ratio	-359.32	81.76	-	-	-	-
Debt / Equity Ratio	0.36	0.32	0.32	0.24	0.19	0.09
Debt / EBITDA Ratio	7.59	16.11	-	-	-	-
Debt / FCF Ratio	-	14.98	-	-	-	-
Asset Turnover	0.71	0.66	0.53	0.41	0.36	0.38
Inventory Turnover	1.34	1.46	1.28	1.17	1.16	2.15
Quick Ratio	1.47	1.72	1.59	2.59	3.76	1.76
Current Ratio	3.74	4.03	3.32	5.06	6.16	3.26
Return on Equity (ROE)	-3.31%	-5.55%	-8.14%	-13.91%	-34.70%	-24.86%
Return on Assets (ROA)	0.50%	-0.55%	-2.72%	-5.21%	-5.84%	-13.17%
Return on Capital (ROIC)	0.57%	-0.63%	-3.09%	-5.79%	-6.54%	-15.09%
Earnings Yield	-3.76%	-3.67%	-5.64%	-9.43%	-24.10%	-60.33%
FCF Yield	-0.34%	1.34%	-3.50%	-8.90%	-14.74%	-61.60%
Buyback Yield / Dilution	-0.27%	-0.12%	-0.02%	-58.13%	-279.54%	-0.02%

Updated Sep 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.